Home Current Issue Previous Issues Publish Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > March 2013 - Volume 35 - Issue 2 > Detection, Control, and Management of a Respiratory Syncytia...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3182756edc
Original Articles

Detection, Control, and Management of a Respiratory Syncytial Virus Outbreak in a Pediatric Hematology-Oncology Department

Shachor-Meyouhas, Yael MD*; Zaidman, Irina MD, PhD; Kra-Oz, Zipi PhD; Arad-Cohen, Nira MD; Kassis, Imad MD*

Collapse Box

Abstract

Background: Immunocompromised patients are at increased risk for severe respiratory syncytial virus (RSV) infection. Palivizumab is approved for prevention of RSV in specific populations but not for treatment. Few studies demonstrated the safety and successful treatment with intravenous (IV) palivizumab. We describe our experience with IV palivizumab treatment for RSV in a pediatric hematology-oncology department during an outbreak.

Methods: During a short period of renovations, oncology patients were placed in a general pediatric ward. After a case of severe fatal RSV pneumonia in a 2-year-old male patient with acute myeloid leukemia, all patients were actively screened twice weekly regardless of symptoms. Respiratory samples were tested for RSV using rapid immunochromatography detection, immunofluorescence, or reverse transcriptase polymerase chain reaction. A single dose of palivizumab (15 mg/kg) was given to children below 3 years of age who tested positive for RSV.

Results: Over a 6-week period, 12 patients tested positive for RSV. Seven patients were treated with palivizumab. Five patients had respiratory symptoms, and 2 were asymptomatic. No adverse events were attributed to IV palivizumab treatment. Early-treated patients had no complications attributed to RSV.

Conclusions: Containment of RSV outbreak in high-risk children is difficult. Screening with reverse transcriptase polymerase chain reaction and the early use of IV palivizumab is safe and may prevent complications of RSV infection among these patients.

© 2013 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.